TRIMETHOPRIM - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for trimethoprim and what is the scope of freedom to operate?

Trimethoprim is the generic ingredient in five branded drugs marketed by Monarch Pharms, Dr Reddys Labs Sa, Novel Labs Inc, Novitium Pharma, Sun Pharm Industries, Teva, Watson Labs, Roche, and Allegis, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-four drug master file entries for trimethoprim. Six suppliers are listed for this compound.

Summary for TRIMETHOPRIM

US Patents:	0
Tradenames:	5
Applicants:	9
NDAs:	11
Drug Master File Entries:	34
Finished Product Suppliers / Packagers:	6
Raw Ingredient (Bulk) Api Vendors:	172
Clinical Trials:	186
Patent Applications:	7,123
Drug Prices:	Drug price trends for TRIMETHOPRIM
What excipients (inactive ingredients) are in TRIMETHOPRIM?	TRIMETHOPRIM excipients list
DailyMed Link:	TRIMETHOPRIM at DailyMed

See drug prices for TRIMETHOPRIM

Drug Sales Revenue Trends for TRIMETHOPRIM

See drug sales revenues for TRIMETHOPRIM

Recent Clinical Trials for TRIMETHOPRIM

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Cairo University	Phase 4
Johns Hopkins University	Early Phase 1
Chang Gung Memorial Hospital	Phase 1/Phase 2

See all TRIMETHOPRIM clinical trials

Pharmacology for TRIMETHOPRIM

Drug Class	Dihydrofolate Reductase Inhibitor Antibacterial
Mechanism of Action	Cytochrome P450 2C8 Inhibitors Dihydrofolate Reductase Inhibitors Organic Cation Transporter 2 Inhibitors

Medical Subject Heading (MeSH) Categories for TRIMETHOPRIM

Anti-Infective Agents, Urinary
Antimalarials
Cytochrome P-450 CYP2C8 Inhibitors
Folic Acid Antagonists

Anatomical Therapeutic Chemical (ATC) Classes for TRIMETHOPRIM

J01EA	Trimethoprim and derivatives
J01E	SULFONAMIDES AND TRIMETHOPRIM
J01	ANTIBACTERIALS FOR SYSTEMIC USE
J	Antiinfectives for systemic use

US Patents and Regulatory Information for TRIMETHOPRIM

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Roche	TRIMPEX 200	trimethoprim	TABLET;ORAL	017952-002	Nov 9, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Novel Labs Inc	TRIMETHOPRIM	trimethoprim	TABLET;ORAL	091437-001	Jun 15, 2011	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Allegis	PRIMSOL	trimethoprim hydrochloride	SOLUTION;ORAL	074973-001	Jan 24, 2000		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.